• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stryker to pay $700m for Novadaq

Stryker to pay $700m for Novadaq

June 19, 2017 By Brad Perriello

Stryker acquires NovadaqNovadaq Technologies (TSE:NVDQ) said today that it agreed to a $700 million offer from Stryker (NYSE:SYK) for its line of fluorescence imaging technology.

Mississauga, Ontario-based Novadaq said the $11.75-per-share offer is a 95.8% premium on its $6 closing price June 16, for a valuation of roughly $701 million; Stryker said that includes some $47 million in net cash. The deal, expected to close during the 3rd quarter, includes a $21 million breakup fee provision, Novadaq said.

At least 66⅔% of the quorum at a special meeting, slated for August 4, must vote in favor of the deal under Canadian business law, Novadaq said. The company’s board is unanimously recommending approval and financial advisors Piper Jaffray and Perella Weinberg Partners certified that the deal is “fair from a financial point of view,” according to a press release.

“This transformative transaction recognizes the exceptional value we have built at Novadaq. Moreover, we believe it creates a strong opportunity for Novadaq, its customers, partners, shareholders and employees,” president & CEO Rick Mangat said in prepared remarks. “I am proud of the impact our Spy and Pinpoint technology has made throughout the world in breast reconstruction and colorectal surgery, as well as other minimally invasive applications, and look forward to the additional progress we can make as part of Stryker’s organization.”

“This acquisition aligns with our focus on enabling our customers to see and do more by enhancing cross-specialty surgical visualization,” added Stryker medsurg & neurotechnology president Timothy Scannell. “Novadaq’s unique, innovative technology complements our advanced imaging portfolio and expands our product offerings into open and plastic reconstructive surgery. Their innovative technology can reduce post-procedure complication rates and the cost of care for a broad variety of surgical treatments.”

Stryker said it expects the buyout to dilute adjusted net earnings per share by 3¢ to 5¢ this year, but stood fast on its forecast for 2017 adjusted EPS of $6.35 to $6.45. The acquisition should be neutral next year and accretive after that, Stryker said.

In addition to Piper Jaffray and Perella Weinberg, Novadaq used Stikeman Elliott and Dechert as legal advisors; Stryker tapped Covington & Burling and Osler, Hoskin & Harcourt for legal counsel on the deal.

NVDQ shares were up 95.5% to $11.73 apiece today in pre-market trading; SYK shares ticked 0.3% to $142.68 each before the open.

Filed Under: Imaging, Mergers & Acquisitions, Surgical, Wall Street Beat Tagged With: Novadaq, Stryker

More recent news

  • Vicarious Surgical inks surgical robot collab with hospital, eyes first clinical patients
  • Bioliberty launches hub for soft-robotic wearable devices
  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy